PHAS
Wellington Management Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,674,690
| Closed | -$2.21M | – | 2238 |
|
|
2022
Q1 | $2.21M | Sell |
1,674,690
-1,194,960
| -42% | -$1.58M | ﹤0.01% | 1575 |
|
|
2021
Q4 | $7.49M | Sell |
2,869,650
-1,155,008
| -29% | -$3.01M | ﹤0.01% | 1346 |
|
|
2021
Q3 | $12.5M | Sell |
4,024,658
-515,239
| -11% | -$1.6M | ﹤0.01% | 1207 |
|
|
2021
Q2 | $16.9M | Sell |
4,539,897
-233,021
| -5% | -$867K | ﹤0.01% | 1130 |
|
|
2021
Q1 | $16.5M | Buy |
4,772,918
+3,205,262
| +204% | +$11.1M | ﹤0.01% | 1114 |
|
|
2020
Q4 | $5.27M | Sell |
1,567,656
-1,761,606
| -53% | -$5.92M | ﹤0.01% | 1315 |
|
|
2020
Q3 | $11.7M | Sell |
3,329,262
-686,967
| -17% | -$2.41M | ﹤0.01% | 1064 |
|
|
2020
Q2 | $18.5M | Sell |
4,016,229
-11,055
| -0.3% | -$50.9K | ﹤0.01% | 943 |
|
|
2020
Q1 | $13.3M | Buy |
4,027,284
+135,028
| +3% | +$447K | ﹤0.01% | 974 |
|
|
2019
Q4 | $23.8M | Sell |
3,892,256
-20,471
| -0.5% | -$125K | 0.01% | 940 |
|
|
2019
Q3 | $16.3M | Buy |
3,912,727
+17,514
| +0.4% | +$73K | ﹤0.01% | 1023 |
|
|
2019
Q2 | $51.1M | Buy |
3,895,213
+465,434
| +14% | +$6.11M | 0.01% | 749 |
|
|
2019
Q1 | $32.6M | Buy |
3,429,779
+58,819
| +2% | +$559K | 0.01% | 873 |
|
|
2018
Q4 | $10.4M | Buy |
+3,370,960
| New | +$10.4M | ﹤0.01% | 1172 |
|